3.76
Schlusskurs vom Vortag:
$3.58
Offen:
$3.67
24-Stunden-Volumen:
7,902
Relative Volume:
0.84
Marktkapitalisierung:
$136.31M
Einnahmen:
$7.80M
Nettoeinkommen (Verlust:
$-69.02M
KGV:
-1.7559
EPS:
-2.1413
Netto-Cashflow:
$-66.61M
1W Leistung:
-3.34%
1M Leistung:
-7.39%
6M Leistung:
-29.06%
1J Leistung:
-46.68%
Molecular Partners Ag Adr Stock (MOLN) Company Profile
Firmenname
Molecular Partners Ag Adr
Sektor
Branche
Telefon
-
Adresse
-
Vergleichen Sie MOLN mit anderen Aktien
Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
---|---|---|---|---|---|---|
![]()
MOLN
Molecular Partners Ag Adr
|
3.76 | 136.31M | 7.80M | -69.02M | -66.61M | -2.1413 |
![]()
VRTX
Vertex Pharmaceuticals Inc
|
441.30 | 115.95B | 11.10B | -988.90M | -1.26B | -3.92 |
![]()
REGN
Regeneron Pharmaceuticals Inc
|
521.00 | 56.52B | 14.09B | 4.50B | 2.96B | 39.28 |
![]()
ALNY
Alnylam Pharmaceuticals Inc
|
322.83 | 39.44B | 2.35B | -269.70M | -75.39M | -2.09 |
![]()
ARGX
Argen X Se Adr
|
560.14 | 35.14B | 2.58B | 1.06B | -1.28B | 16.33 |
![]()
ONC
Beone Medicines Ltd Adr
|
241.20 | 28.51B | 3.81B | -644.79M | -669.77M | -6.24 |
Molecular Partners Ag Adr Stock (MOLN) Upgrades & Downgrades
Datum | Aktion | Analytiker | Ratingänderung |
---|---|---|---|
2022-08-30 | Herabstufung | RBC Capital Mkts | Outperform → Sector Perform |
2022-08-29 | Herabstufung | SVB Leerink | Outperform → Mkt Perform |
2022-05-25 | Hochstufung | Credit Suisse | Underperform → Neutral |
2022-04-27 | Herabstufung | Credit Suisse | Neutral → Underperform |
2021-07-13 | Eingeleitet | Cowen | Outperform |
2021-07-12 | Fortgesetzt | SVB Leerink | Outperform |
Alle ansehen
Molecular Partners Ag Adr Aktie (MOLN) Neueste Nachrichten
Molecular Partners presents positive data from ongoing Phase 1/2a trial of MP0533 in AML at EHA 2025 - GlobeNewswire Inc.
Walmart, Deere, Applied Materials set to report earnings Thursday By Investing.com - Investing.com Nigeria
Walmart, Deere, Applied Materials set to report earnings Thursday - Investing.com
Ziff Davis Inc (NASDAQ:ZD) Shares Jumped 1.54% In A Week. Can It Continue Rising? - Marketing Sentinel
Can Contango ORE, Inc. (CTGO) Climb 163.28% to Reach the Level Wall Street Analysts Expect? - Yahoo Finance
Here's Why Molecular Partners AG Sponsored ADR (MOLN) Could be Great Choice for a Bottom Fisher - Yahoo Finance
Musk's DOGE Exit Rumors & Weak Q1 Deliveries: How to Play Tesla Now - Yahoo Finance
Why Tractor Supply (TSCO) is a Top Momentum Stock for the Long-Term - Yahoo Finance
TD Cowen maintains Buy on Molecular Partners, target CHF15 - Investing.com India
Molecular Partners reports 2024 annual results - Investing.com India
Wall Street Analysts Think Molecular Partners AG Sponsored ADR (MOLN) Could Surge 80.72%: Read This Before Placing a Bet - Yahoo Finance
Molecular Partners, Orano Med announce presentation of MP0712 data - TipRanks
Why Sarepta Therapeutics Shares Are Trading Higher By Around 35%; Here Are 20 Stocks Moving Premarket - Benzinga
US stock market gainers for the last week of April 2022 - Nairametrics
Novartis to push forward with covid drug after positive results - Luxembourg Times
Wall Street Analysts See a 96% Upside in Molecular Partners AG Sponsored ADR (MOLN): Can the Stock Really Move This High? - Yahoo Finance
Citi Appointed as Depositary Bank for Molecular Partners AG’s ADR Programme - Business Wire
Finanzdaten der Molecular Partners Ag Adr-Aktie (MOLN)
Umsatz
Nettogewinn
Free Cashflow
ENV
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):